VWR Publishes 2017 Sustainability Report

RADNOR, Pa., May 23, 2017 /PRNewswire/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, has published its sixth annual Sustainability Report. Detailing the Company’s global sustainability efforts, the report describes VWR’s steady progress in addressing and improving the environmental, economic and social impacts of... Read more

Reminder: Invitation to Roche Analyst Event at ASCO 2017

Basel, 23 May 2017 Reminder: Invitation to Roche Analyst Event at ASCO 2017 Monday, 5 June 2017, 5:15pm CDT We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (2 –... Read more

Find the Missing Links in Advanced Live Cell Research – Leica launches DMi8 S live cell imaging solution

The DMi8 S with LASX Navigator allows researchers to quickly create high resolution overviews like the whole mouse brain in this example. This facilitates orientation on the sample and easy discovery of critical regions for further examination. Image courtesy of Dr. Wei Mo, School of Life Sciences, Xiamen University, China. “Live-cell imaging is the future... Read more

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis

Basel, 23 May 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche (SIX: RO, ROG; OTCQX:... Read more

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis

Basel, 23 May 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche (SIX: RO, ROG; OTCQX:... Read more

Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied BiosystemsTM SeqStudioTM Genetic Analyzer

Thermo Fisher Scientific, the world leader in serving science, launched today a new capillary electrophoresis (CE) system designed to offer a low-throughput, cartridge-based system for Sanger sequencing and fragment analysis. For use with oncology research, genome editing, species identification, and human cell line authentication among other common applications, the Applied Biosystems™ SeqStudio™ Genetic Analyzer supports... Read more

Nikon Instruments Introduces New Silicone Immersion Objective Lens for Super-Resolution and Multi-Modal Imaging

MELVILLE, N.Y., May 22, 2017 (GLOBE NEWSWIRE) — Nikon Instruments Inc. today unveiled a new silicone immersion objective lens, CFI SR HP Plan Apochromat Lambda S 100XC Sil, for super-resolution and multi-modal imaging. The new silicone immersion objective lens from Nikon provides high numerical aperture and long working distance to enable super-resolution imaging of thick... Read more

Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer. Van Oene was previously Illumina’s Senior Vice President of the Americas region and subsequently named interim Chief Commercial Officer in late 2016. “Mark is a great leader for our commercial organization, possessing deep genomics expertise and over a... Read more

Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome Analysis

MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) — A series of recent peer-reviewed scientific publications highlights the growing use of Single Molecule, Real-Time (SMRT®) Sequencing to annotate plant and animal genomes. These reports from the genomics community show that PacBio sequencing consistently detects more genes, alternative splicing events, and other important elements compared with... Read more